CAR T Outcomes in LBCL: US Flatiron EMR Real-World Findings
 |
| ASH 2025 - LBCL in Focus: Transforming Outcomes with CAR-T Therapy Panelists examine evolving second-line treatment strategies for relapsed/refractory large B-cell lymphoma, highlighting key trial updates, real-world evidence, and practical decision-making considerations. The discussion reviews long-term findings from the TRANSFORM and ZUMA-7 studies alongside emerging real-world data on CAR T utilization, outcomes, and access. |
|
|
Featured Video |
-Mar-12-2026-08-12-40-9375-PM.png?width=580&upscale=true&name=MarketingWS%20(1)-Mar-12-2026-08-12-40-9375-PM.png) |
| CAR T Outcomes in LBCL: US Flatiron EMR Real-World Findings Panelists analyze real-world outcomes for patients receiving CAR T therapy in LBCL using US electronic medical record data from Flatiron Health. |
|